Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.news-medical.net/news/20230215/Neoadjuvant-nivolumab-treatment-improves-survival-rates-in-NSCLC-patients.aspx
0
0
Neoadjuvant nivolumab treatment improves survival rates in NSCLC patients - News-Medical.Net
+ 15 more
2/15/23 at 7:42pm
Organization
News-Medical.Net
Authors
Details
41 words
Summarize
Cancer
Health
nivolumab treatment
NSCLC
Patients with resectable non-small cell lung cancer (NSCLC) who were treated with neoadjuvant nivolumab had improved five-year recurrence-free and overall survival rates compared with historical outcomes.
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...